SYNTHESIS AND PLATELET-ACTIVATING-FACTOR (PAF)-ANTAGONISTIC ACTIVITIES OF 1,4-DISUBSTITUTED PIPERAZINE DERIVATIVES

被引：0
|
作者：
FUKUSHI, H
MABUCHI, H
ITOH, K
TERASHITA, Z
NISHIKAWA, K
SUGIHARA, H
机构：
[1] TAKEDA CHEM IND LTD, PHARMACEUT RES LABS 2, YODOGAWA KU, OSAKA 532, JAPAN
[2] TAKEDA CHEM IND LTD, PHARMACEUT RES LABS 3, YODOGAWA KU, OSAKA 532, JAPAN
[3] TAKEDA CHEM IND LTD, DIV PHARMACEUT RES, OSAKA 532, JAPAN
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 1994年 / 42卷 / 03期
关键词：
PAF ANTAGONIST; STRUCTURE ACTIVITY RELATIONSHIP; 1,4-DISUBSTITUTED PIPERAZINE; 1-(6-METHOXY-3,4-DIHYDRO-2-NAPHTHOYL)-4-(3,4,5-TRIMETHOXYBENZYL)PIPERAZINE; 1-(2,3-DIMETHOXY-6,7-DIHYDRO-5H-BENZOCYCLOHEPTEN-8-YLCARBONYL)-4-(3,4,5-TRIMETHOXYBENZOYL)PIPERAZINE;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
During the screening of novel platelet-activating factor (PAF) antagonists, we found that 1-(6-methoxy-3,4-dihydro-2-naphthoyl)-4-(3,4,5-trimethoxybenzyl)piperazine and its 4-(3,4,5-trimethoxybenzoyl)piperazine derivatives (1b, 2b) exerted in vitro and in vivo PAF-antagonistic activities. Modifications of the 1-acyl group, the substituent at the 4-position and the piperazine ring of 1a and 2b were examined and from this series 1-(2,3-dimethoxy-6,7-dihydro-5H-benzocyclohepten-8-ylcarbonyl)-4-(3,4,5-trimethoxybenzoyl)piperazine (2g) was found to be one of the most potent PAF antagonists.
引用
收藏
页码：541 / 550
页数：10
相关论文
共 50 条
  • [41] ANTIBODIES TO PLATELET-ACTIVATING-FACTOR (PAF) INHIBIT PAF-INDUCED PLATELET-AGGREGATION
    SMAL, MA
    COONEY, SJ
    BALDO, BA
    JOURNAL OF LIPID MEDIATORS, 1991, 4 (03): : 333 - 341
  • [42] ISOLATION AND CHARACTERIZATION OF HUMAN SALIVARY PLATELET-ACTIVATING-FACTOR (PAF)
    SMITH, SA
    MCMANUS, LM
    SCHIESS, AV
    JOURNAL OF DENTAL RESEARCH, 1986, 65 : 232 - 232
  • [43] SUBCELLULAR AND TISSUE DISTRIBUTION OF PLATELET-ACTIVATING-FACTOR (PAF) TRANSACETYLASE
    OU, MC
    LEE, TC
    SNYDER, F
    FASEB JOURNAL, 1994, 8 (07): : A1402 - A1402
  • [44] THE ROLE OF PLATELET-ACTIVATING-FACTOR (PAF) IN EXPERIMENTAL GLOMERULAR INJURY
    ORTIZ, A
    GOMEZCHIARRI, M
    LERMA, JL
    GONZALEZ, E
    EGIDO, J
    LIPIDS, 1991, 26 (12) : 1310 - 1315
  • [45] PLATELET-ACTIVATING-FACTOR (PAF) EFFECTS IN LAMB PULMONARY CIRCULATION
    TOGA, H
    HILLYARD, R
    ANDERSON, J
    RAJ, JU
    FASEB JOURNAL, 1991, 5 (05): : A1027 - A1027
  • [46] DENOVO BIOSYNTHESIS OF ALKYLACETYLGLYCEROLS, A PRECURSOR OF PLATELET-ACTIVATING-FACTOR (PAF)
    MALONE, B
    LEE, TC
    SNYDER, F
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1529 - 1529
  • [47] INFLAMMATORY EFFECTS OF PLATELET-ACTIVATING-FACTOR (PAF) IN EQUINE SKIN
    FOSTER, AP
    CUNNINGHAM, FM
    LEES, P
    EQUINE VETERINARY JOURNAL, 1992, 24 (03) : 208 - 214
  • [48] EFFECTS OF PLATELET-ACTIVATING-FACTOR (PAF) ON RAT JEJUNAL MUCOSA
    HANGLOW, AC
    BIENENSTOCK, J
    DYCK, N
    PERDUE, MH
    GASTROENTEROLOGY, 1987, 92 (05) : 1424 - 1424
  • [49] METABOLISM OF PLATELET-ACTIVATING-FACTOR (PAF) BY RABBIT RENAL HOMOGENATES
    CAGEN, LM
    YEH, YM
    BAER, PG
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1530 - 1530
  • [50] PLATELET-ACTIVATING-FACTOR (PAF) AS A MEDIATOR OF INJURY IN NEPHROTOXIC NEPHRITIS
    BERTANI, T
    LIVIO, M
    MACCONI, D
    MORIGI, M
    BISOGNO, G
    PATRONO, C
    REMUZZI, G
    KIDNEY INTERNATIONAL, 1987, 31 (06) : 1248 - 1256
12345